Canton Strategic Holdings (CNTN) Retained Earnings (2020 - 2026)
Canton Strategic Holdings posted quarterly Retained Earnings of -$120.2 million for Q1 2026, down 204.65% year-on-year from $114.8 million in Q1 2025, and down 65.02% on a QoQ basis from -$72.8 million in Q4 2025.
Canton Strategic Holdings (CNTN) has 7 years of Retained Earnings data on file, last reported at -$120.2 million in Q1 2026.
- For the quarter ending Q1 2026, Retained Earnings fell 204.65% year-over-year to -$120.2 million; the trailing twelve-month figure through Mar 2026 stood at -$120.2 million (down 204.65% YoY), and the FY2025 full-year result was -$72.8 million, down 97.33% from the prior year.
- Retained Earnings for Q1 2026 stood at -$120.2 million, down from -$72.8 million in the prior quarter.
- Across five years, Retained Earnings topped out at -$9.9 million in Q1 2022 and bottomed at -$120.2 million in Q1 2026.
- The 5-year median for Retained Earnings is -$27.0 million (2024), against an average of -$34.1 million.
- The widest annual swing landed in 2025, when Retained Earnings tumbled 31.12%; it then tumbled 204.65% in 2026.
- A 5-year view of Retained Earnings shows it stood at -$15.4 million in 2022, then sank by 60.57% to -$24.7 million in 2023, then sank by 49.38% to -$36.9 million in 2024, then tumbled by 97.33% to -$72.8 million in 2025, then plunged by 65.02% to -$120.2 million in 2026.
- The last three Retained Earnings figures came in at -$120.2 million (Q1 2026), -$72.8 million (Q4 2025), and -$43.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -211.85 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | -153.89 Mn |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 1.00 Bn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | -438.66 Mn |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -279.00 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 14.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 130.89 Mn |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 36.42 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -24.89 Mn |
| 10 | Canton Strategic Holdings | 643.89 Mn | 602.36 Mn | - | -120.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -120.16 Mn |
| Dec 31, 2025 | -72.82 Mn |
| Sep 30, 2025 | -43.40 Mn |
| Jun 30, 2025 | -41.30 Mn |
| Mar 31, 2025 | -39.44 Mn |
| Dec 31, 2024 | -36.90 Mn |
| Sep 30, 2024 | -33.10 Mn |
| Jun 30, 2024 | -29.28 Mn |
| Mar 31, 2024 | -27.00 Mn |
| Dec 31, 2023 | -24.70 Mn |
| Sep 30, 2023 | -22.20 Mn |
| Jun 30, 2023 | -20.41 Mn |
| Mar 31, 2023 | -18.07 Mn |
| Dec 31, 2022 | -15.38 Mn |
| Sep 30, 2022 | -13.62 Mn |
| Jun 30, 2022 | -11.49 Mn |
| Mar 31, 2022 | -9.85 Mn |
| Dec 31, 2021 | -6.91 Mn |
| Dec 31, 2020 | -4.70 Mn |